Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy

被引:2
|
作者
Panagiotou, Marios [1 ]
Koulouris, Nikolaos [1 ]
Koutsoukou, Antonia [1 ]
Tsami, Maria [2 ]
Syrigou, Ekaterini [3 ]
Rovina, Nikoletta [1 ]
机构
[1] Univ Athens, Dept Resp Med 1, Sotiria Thorac Dis Gen Hosp, Athens, Greece
[2] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
[3] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
关键词
Asthma; -; management; Physical activity; Adults;
D O I
10.1183/13993003.congress-2019.PA1648
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA1648
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
    Menzella, Francesco
    Ruggiero, Patrizia
    Ghidoni, Giulia
    Fontana, Matteo
    Bagnasco, Diego
    Livrieri, Francesco
    Scelfo, Chiara
    Facciolongo, Nicola
    JOURNAL OF ASTHMA AND ALLERGY, 2020, 13 : 301 - 313
  • [42] Reduction in FeNO on anti-IL5 biologics is associated with clinical remission of severe asthma
    Soendergaard, Marianne Baastrup
    Hansen, Susanne
    Haakansson, Kjell Erik Julius
    Von Bulow, Anna
    Bjerrum, Anne-Sofie
    Schmid, Johannes Martin
    Johnsen, Claus Rikard
    Hilberg, Ole
    Ulrik, Charlotte Suppli
    Porsbjerg, Celeste
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [43] DEVELOPMENT OF A DEDICATED PROTOCOL FOR SCREENING FOR OCCULT PARASITIC INFECTION PRIOR TO INITIATION OF ANTI-IL5 THERAPY IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Cushen, B.
    Stead, R.
    Malley, S.
    Armstrong-James, D.
    Hull, J.
    THORAX, 2019, 74 : A36 - A36
  • [44] Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
    Maglio, Angelantonio
    Vitale, Carolina
    Pellegrino, Simona
    Calabrese, Cecilia
    Parente, Roberta
    Triggiani, Massimo
    Stellato, Cristiana
    Pelaia, Corrado
    Pelaia, Girolamo
    Vatrella, Alessandro
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [45] Worldwide Characterization of Severe Asthma Patients Eligible for Both Anti-IL5 and Anti-IgE: Data from the International Severe Asthma Registry (ISAR)
    Sadatsafavi, M.
    Murray, R.
    Ali, N.
    Trung, T.
    Price, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [46] CHANGE IN FENO AS A BIOMARKER OF RESPONSE TO ANTI-IL5/5R THERAPIES IN SEVERE ASTHMA
    Hearn, A. P.
    Kavanagh, J. E.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2022, 77 : A80 - A80
  • [47] Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
    Carpagnano, Giovanna Elisiana
    Portacci, Andrea
    Nolasco, Santi
    Detoraki, Aikaterini
    Vatrella, Alessandro
    Calabrese, Cecilia
    Pelaia, Corrado
    Montagnolo, Francesca
    Scioscia, Giulia
    Valenti, Giuseppe
    D'Amato, Maria
    Caiaffa, Maria Filomena
    Triggiani, Massimo
    Scichilone, Nicola
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort
    Bal, C.
    Idzko, M.
    Milger-Kneidinger, K.
    Skowasch, D.
    Schulz, C.
    Taube, C.
    Hamelmann, E.
    Buhl, R.
    Korn, S.
    PNEUMOLOGIE, 2023, 77 : S46 - S46
  • [49] The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort
    Bal, C.
    Idzko, M.
    Milger, K.
    Skowasch, D.
    Schulz, C.
    Taube, C.
    Hamelmann, E.
    Buhl, R.
    Korn, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhairwal, Jaideep
    Nanzer, Alexandra M.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56